Kenji Yamao Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

1/2020	A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
1/2017	Health-related quality of life in a randomised phase III study of gemcitabine plus S-1, S-1 alone and gemcitabine alone for locally advanced or metastatic pancreatic cancer: GEST study.
1/2017	Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients.
9/2016	Prognostic impact of carcinoembryonic antigen (CEA) on patients with metastatic pancreatic cancer: A retrospective cohort study.
2/2016	Clinical outcome of elderly patients with unresectable pancreatic cancer treated with gemcitabine plus S-1, S-1 alone, or gemcitabine alone: Subgroup analysis of a randomised phase III trial, GEST study.
1/2016	Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.
7/2015	Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC Study.
3/2014	Clinical characteristics of adenosquamous carcinoma of the pancreas: a matched case-control study.
11/2013	Phase I/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancer.
5/2013	Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenji Yamao Research Topics

Disease

34	Neoplasms (Cancer) 01/2020 - 01/2002
26	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 10/2006
10	Adenocarcinoma 12/2021 - 03/2007
9	Carcinoma (Carcinomatosis) 12/2014 - 03/2004
7	Pathologic Constriction (Stenosis) 05/2018 - 07/2009
7	Stomach Neoplasms (Stomach Cancer) 07/2013 - 11/2007
5	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2011 - 01/2003
5	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2009 - 01/2002
4	Neoplasm Metastasis (Metastasis) 10/2016 - 01/2003
4	Autoimmune Pancreatitis 01/2012 - 01/2009
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2019 - 10/2013
3	Adenoma (Adenomas) 01/2017 - 07/2009
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2013 - 07/2009
2	Neoplasms, Cystic, Mucinous, and Serous 03/2023 - 02/2019
2	Adenosquamous Carcinoma 03/2023 - 01/2013
2	Fever (Fevers) 04/2018 - 09/2014
2	Chronic Pancreatitis 11/2017 - 01/2009
2	Pancreatitis 11/2017 - 02/2003
2	Hepatocellular Carcinoma (Hepatoma) 05/2016 - 07/2012
2	Colonic Neoplasms (Colon Cancer) 12/2015 - 10/2011
2	Cysts 10/2015 - 11/2014
2	Colorectal Neoplasms (Colorectal Cancer) 08/2015 - 11/2010
2	Carcinogenesis 07/2013 - 01/2002
2	Anorexia 01/2013 - 04/2008
2	Disease Progression 10/2011 - 03/2007
2	Obstructive Jaundice (Cholestatic Jaundice) 09/2010 - 02/2009
2	Hemorrhage 08/2005 - 02/2003
1	Meningeal Carcinomatosis 12/2021
1	Suppuration 05/2018
1	Cholangitis 11/2017
1	Pancreatic Ductal Carcinoma 01/2017
1	Esophageal Squamous Cell Carcinoma 08/2016
1	Esophageal Neoplasms (Esophageal Cancer) 08/2016
1	Cecal Neoplasms 12/2015
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 10/2015
1	Gastric Outlet Obstruction 01/2015
1	Bile Duct Neoplasms (Bile Duct Cancer) 12/2014
1	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2014

Drug/Important Bio-Agent (IBA)

13	Gemcitabine FDA Link 12/2021 - 05/2006
7	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2010
4	AntigensIBA 01/2020 - 10/2009
4	CarbohydratesIBA 01/2020 - 01/2010
4	Indicators and Reagents (Reagents)IBA 11/2013 - 06/2009
4	Imatinib Mesylate (Gleevec)FDA Link 01/2011 - 01/2003
3	Carcinoembryonic AntigenIBA 01/2020 - 07/2012
3	Sunitinib (Sutent)FDA Link 06/2019 - 01/2011
3	PlasticsIBA 11/2017 - 02/2009
3	Peptides (Polypeptides)IBA 01/2017 - 11/2013
3	Tumor Biomarkers (Tumor Markers)IBA 09/2016 - 11/2014
3	Protein Subunit VaccinesIBA 05/2016 - 07/2012
3	perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)IBA 01/2016 - 02/2009
3	Proteins (Proteins, Gene)FDA Link 11/2013 - 01/2003
3	EnzymesIBA 05/2010 - 10/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2015
2	EpitopesIBA 01/2017 - 11/2013
2	CA-19-9 Antigen (CA 19-9 Antigen)IBA 05/2013 - 01/2010
2	ABO Blood-Group SystemIBA 01/2013 - 05/2011
2	Insulin (Novolin)FDA Link 12/2011 - 01/2011
2	Calcibiotic Root Canal SealerIBA 04/2011 - 11/2010
2	Neoplasm Antigens (Tumor Antigens)IBA 11/2010 - 01/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2010 - 05/2010
2	UracilIBA 12/2009 - 09/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2009 - 09/2006
2	TegafurIBA 12/2009 - 09/2006
2	C-Reactive ProteinIBA 08/2008 - 06/2004
1	Codon (Codons)IBA 03/2023
1	130-nm albumin-bound paclitaxelIBA 12/2021
1	Cell-Free Nucleic AcidsIBA 01/2020
1	MucinsIBA 02/2019
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017
1	OCV-C01IBA 01/2017
1	VaccinesIBA 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2016
1	Capsules (Microcapsules)IBA 10/2015
1	Immunoglobulin D (IgD)IBA 10/2015
1	DioxygenasesIBA 08/2015
1	Pyridinolcarbamate (P23)IBA 08/2015
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2015
1	arginyl- phenylalanyl- valyl- prolyl- aspartyl- glycyl- asparagyl- arginyl- isoleucineIBA 07/2015
1	Protons (Proton)IBA 12/2014
1	SolventsIBA 12/2014
1	Amylases FDA Link 11/2014

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 01/2017 - 09/2004
10	Therapeutics 05/2016 - 05/2006
8	Stents 04/2018 - 08/2005
8	Pancreaticoduodenectomy 01/2017 - 03/2004
7	Radiotherapy 08/2016 - 09/2004
4	Pancreatectomy 01/2017 - 08/2005
4	Restorative Proctocolectomy 01/2017 - 07/2009
2	Self Expandable Metallic Stents 01/2017 - 01/2015
2	Chemoradiotherapy 08/2016 - 01/2009
2	Hepatectomy 12/2015 - 09/2010
2	Immunotherapy 11/2013 - 07/2012
2	Endoscopic Sphincterotomy 07/2012 - 02/2003
2	Combination Drug Therapy (Combination Chemotherapy) 12/2009 - 09/2006
1	Cannula 05/2018
1	Operative Time 10/2016
1	Adjuvant Chemotherapy 07/2016
1	Operative Surgical Procedures 12/2015